This article describes the factors contributing to ethnic health disparities and their impact on health equity in the United States. Historical examples of infectious diseases, such as smallpox, yellow fever, polio, HIV, and COVID-19, illustrate racial mortality differences that were eliminated by removing the diseases. In addition, disparities in cardiovascular death risk factors, including hypertension, type 2 diabetes, inflammation, hyperlipidemia, chronic kidney disease (CKD), and obesity, are examined. The adoption of whole food plant-based (WFPB) diets is proposed as a practical and culturally sensitive solution to mitigate these disparities and promote health equity. Evidence-based strategies are discussed to support implementation.
FennEA. Pox Americana: The Great Smallpox Epidemic of 1775–82. Hill and Wang; 2001.
2.
CrosbyAW. Virgin soil epidemics as a factor in the aboriginal depopulation in America. William Mary Q. 1976;33(2):289-299.
3.
McNeillJR. Mosquito Empires: Ecology and War in the Greater Caribbean, 1620–1914. Cambridge: Cambridge University Press; 2010.
4.
CurtinPD. Death by Migration: Europe's Encounter with the Tropical World in the Nineteenth Century. Cambridge: Cambridge University Press; 1989.
5.
OshinskyDM. Polio: An American Story. Oxford: Oxford University Press; 2005.
6.
RogersN. Race and the politics of polio: warm springs, tuskegee, and the march of dimes. Am J Public Health. 2007;97(5):784-795.
7.
MillettGAPetersonJLFloresSA, et al.Comparisons of disparities and risks of HIV infection in Black and other men who have sex with men in Canada, UK, and USA: a meta-analysis. Lancet. 2012;380(9839):341-348.
8.
QuinnTCOverbaughJ. HIV/AIDS in women: an expanding epidemic. Science. 2005;308(5728):1582-1583.
9.
TaiDBShahADoubeniCASiaIGWielandML. The disproportionate impact of COVID-19 on racial and ethnic minorities in the United States. Clin Infect Dis. 2021;72(4):703-706.
10.
LaurencinCTMcClintonA. The COVID-19 pandemic: a call to action to identify and address racial and ethnic disparities. J Racial Ethn Health Disparities. 2020;7(3):398-402.
11.
FerdinandKCNasserSA. Disparate hypertension prevalence, treatment, and control rates among African Americans: current perspective and call to action. Cardiol Clin. 2017;35(2):229-239.
12.
LacklandDTWeberMA. Global burden of cardiovascular disease and stroke: hypertension at the core. Can J Cardiol. 2015;31(5):569-571.
13.
GoldenSHBrownACauleyJA, et al.Health disparities in endocrine disorders: biological, clinical, and nonclinical factors—an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2012;97(9):E1579-E1639.
AlbertMAGlynnRJRidkerPM. C-reactive protein levels among African Americans and white Americans. Circulation. 2004;109(5):587-592.
16.
MadrigalJMDePierreJAStenvinkelPKalantar-ZadehK. Stress, systemic inflammation, and disparities in cardiovascular disease among African Americans. Front Cardiovasc Med. 2021;8:644430.
17.
EnkhmaaBAnuuradEBerglundL. Lipoprotein (a): impact by ethnicity and environmental factors. J Clin Lipidol. 2011;5(6):435-442.
18.
ArnettDKMcClellandRLBankA, et al.Blood pressure and cholesterol control in Black and white adults: an examination of the NHANES database. J Am Heart Assoc. 2009;119(9):1234-1241.
ParsaAKaoWHXieD, et al.APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013;369(23):2183-2196.
21.
NorrisKAgodoaLUnuigbeE, et al.Racial disparities in chronic kidney disease and end-stage renal disease: the role of systemic racism. J Natl Med Assoc. 2008;100(10):1204-1211.
22.
CouchCAGrayMSShikanyJM, et al.Correlates of a southern diet pattern in a national cohort study of blacks and whites: the REGARDS study. Br J Nutr. 2021;126(12):1904-1910. doi:10.1017/S0007114521000696
23.
OgdenCLCarrollMDKitBKFlegalKM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311(8):806-814. doi:10.1001/jama.2014.732
24.
HalesCMCarrollMDFryarCDOgdenCO. Prevalence of obesity among adults and youth: United States, 2017–2018. NCHS Data Brief. 2020;(36):1-8. https://www.cdc.gov/nchs/data/databriefs/db360-h.pdf. Accessed15 January 2025.
25.
YokoyamaYNishimuraKBarnardND, et al.Vegetarian diets and blood pressure: a meta-analysis. JAMA Intern Med. 2014;174(4):577-587. doi:10.1001/jamainternmed.2013.14547
26.
OrlichMJSinghPNSabatéJ, et al.Vegetarian dietary patterns and mortality in adventist health study 2. JAMA Intern Med. 2013;173(13):1230-1238. doi:10.1001/jamainternmed.2013.6473
27.
BarnardNDCohenJJenkinsDJ, et al.A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care. 2006;29(8):1777-1783. doi:10.2337/dc06-0606
28.
TonstadSStewartKOdaKBatechMHerringRPFraserGE. Vegetarian diets and incidence of diabetes in the adventist health study-2. Nutr Metab Cardiovasc Dis. 2013;23(4):292-299. doi:10.1016/j.numecd.2011.07.004
29.
PanigrahiGGoodwinSMStaffierKLKarlsenM. Remission of type 2 diabetes after treatment with a high-fiber, low-fat, plant-predominant diet intervention: a case series. Am J Lifestyle Med. 2023;17(6):839-846. doi:10.1177/15598276231181574
30.
JusteCGérardP. Cholesterol-to-coprostanol conversion by the gut microbiota: what we know, suspect, and ignore. Microorganisms. 2021;9(9):1881. doi:10.3390/microorganisms9091881
31.
WilliamsKAFughhiIFugarS, et al.Nutrition intervention for reduction of cardiovascular risk in African Americans using the 2019 ACC/AHA primary prevention guidelines. Nutrients. 2021;13(10):3422. doi:10.3390/nu13103422
32.
OrnishDBrownSEScherwitzLW, et al.Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet. 1990;336(8708):129-133. doi:10.1016/0140-6736(90)91656-u
33.
EsselstynCB. A plant-based diet and coronary artery disease: a mandate for effective therapy. J Geriatr Cardiol. 2017;14(5):317-320. doi:10.11909/j.issn.1671-5411.2017.05.004
34.
MishraSXuJAgarwalUGonzalesJLevinSBarnardND. A multicenter randomized controlled trial of a plant-based nutrition program to reduce body weight and cardiovascular risk in the corporate setting: the GEICO study. Eur J Clin Nutr. 2013;67(7):718-724. doi:10.1038/ejcn.2013.92
35.
WongJMde SouzaREmamA, et al.Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA. 2003;290(4):502-510. doi:10.1001/jama.290.4.502
36.
GorayaNSimoniJJoCHWessonDE. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol. 2013;8(3):371-381. doi:10.2215/CJN.02430312
37.
AmirSKimHHuEA, et al.Adherence to plant-based diets and risk of CKD progression and all-cause mortality: findings from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis. 2024;83(5):624-635. doi:10.1053/j.ajkd.2023.09.020
JoshiSMcMackenMKalantar-ZadehK. Plant-based diets for kidney disease: a guide for clinicians. Am J Kidney Dis. 2021;77(2):287-296. doi:10.1053/j.ajkd.2020.10.003
